EV/EBITDA
11.41
+1.36+13.53%
Fri, 07 Feb 2025 21:20:19 GMT
Summary
- As of February 8, 2025, SPRO EV/EBITDA is 11.41, with a rise of +1.36 (+13.53%) during the most recent trading day.
- Over the past year, SPRO EV/EBITDA has increased by +11.17 (+4654.17%).
- SPRO EV/EBITDA is now -8.79% below its all-time high of 12.51.
Performance
SPRO EV/EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
EV/EBITDA Formula
EV/EBITDA = Enterprise Value
TTM EBITDA
Enterprise Value
TTM EBITDA
TTM EBITDA
SPRO EV/EBITDA Trends
| PeriodPeriod | EV/EBITDAEV/EBITDA | Enterprise valueEnterprise value | PricePrice |
|---|---|---|---|
| todaytoday | +13.5% | -13.5% | -7.0% |
| 1 m1 month | +118.2% | -118.3% | -25.7% |
| 3 m3 months | +3455.9% | -3418.7% | -39.7% |
| 6 m6 months | +2435.6% | -453.5% | -34.8% |
| ytdytd | +68.0% | -68.1% | -20.5% |
| 1 y1 year | +4654.2% | -560.7% | -44.7% |
| 5 y5 years | +537.2% | -117.2% | -91.7% |
SPRO EV/EBITDA Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | -8.8% | 5.23 | +118.2% | |
| 3 m | 3-month | 12.51 | -8.8% | -0.34 | +3455.9% |
| 6 m | 6-month | 12.51 | -8.8% | -0.45 | +2635.6% |
| 1 y | 1-year | 12.51 | -8.8% | -0.45 | +2635.6% |
| 3 y | 3-year | 12.51 | -8.8% | -32.17 | +135.5% |
| 5 y | 5-year | 12.51 | -8.8% | -32.17 | +135.5% |
| alltime | all time | 12.51 | -8.8% | -32.17 | +135.5% |
Spero Therapeutics EV/EBITDA History
| Date | Value |
|---|---|
| 2025 | 11.41(+68.0%) |
| 2024 | 6.79(+3133.3%) |
| 2023 | 0.21(-22.2%) |
| 2022 | 0.27(-105.7%) |
| Date | Value |
|---|---|
| 2021 | -4.74(-25.0%) |
| 2020 | -6.32(+145.9%) |
| 2019 | -2.57(+52.1%) |
| 2018 | -1.69(-16.7%) |
| 2017 | -2.03 |
FAQ
- What is Spero Therapeutics EV/EBITDA?
- What is the all time high EV/EBITDA for Spero Therapeutics?
- What is SPRO EV/EBITDA year-to-date change?
- What is Spero Therapeutics EV/EBITDA year-on-year change?
What is Spero Therapeutics EV/EBITDA?
The current EV/EBITDA of SPRO is 11.41
What is the all time high EV/EBITDA for Spero Therapeutics?
Spero Therapeutics all-time high EV/EBITDA is 12.51
What is SPRO EV/EBITDA year-to-date change?
Spero Therapeutics EV/EBITDA has changed by +4.62 (+68.04%) since the beginning of the year
What is Spero Therapeutics EV/EBITDA year-on-year change?
Over the past year, SPRO EV/EBITDA has changed by +11.17 (+4654.17%)